Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Anastasios G. Konstas, Leopold Schmetterer, Vital P. Costa, Gábor Holló, Andreas Katsanos, Philippe Denis, Luciano Quaranta, Murat Irkec, Miguel A. Castejón, Miguel A. Teus & Alan L. Robin. (2020) Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review. Expert Opinion on Drug Safety 19:11, pages 1445-1460.
Read now
Read now
Lindsay Machen, Reza Razeghinejad & Jonathan S. Myers. (2020) Fixed-combination topical anti-hypertensive ophthalmic agents. Expert Opinion on Pharmacotherapy 21:10, pages 1269-1282.
Read now
Read now
Gábor Holló & Andreas Katsanos. (2015) Safety and tolerability of the tafluprost/timolol fixed combination for the treatment of glaucoma. Expert Opinion on Drug Safety 14:4, pages 609-617.
Read now
Read now
Sky K Chew, Simon E Skalicky & Ivan Goldberg. (2014) Brinzolamide plus brimonidine for the treatment of glaucoma: an update. Expert Opinion on Pharmacotherapy 15:16, pages 2461-2471.
Read now
Read now
Katrin Lorenz & Norbert Pfeiffer. (2014) Efficacy and safety of tafluprost 0.0015% and timolol maleate 0.5% fixed combination in patients with ocular hypertension or open-angle glaucoma. Expert Opinion on Pharmacotherapy 15:15, pages 2255-2262.
Read now
Read now
Jin-Wei Cheng, Shi-Wei Cheng, Dan-Yang Yu, Rui-Li Wei & Guo-Cai Lu. (2012) Meta-analysis of α2-adrenergic agonists versus carbonic anhydrase inhibitors as adjunctive therapy. Current Medical Research and Opinion 28:4, pages 543-550.
Read now
Read now
Misha F Syed & Emma KR Loucks. (2011) Update and optimal use of a brinzolamide-timolol fixed combination in open-angle glaucoma and ocular hypertension. Clinical Ophthalmology 5, pages 1291-1296.
Read now
Read now
Articles from other publishers (8)
Qing Ye, Ruolan Xu, Dan Li, Yu Kang, Yafeng Deng, Feng Zhu, Jiming Chen, Shibo He, Chang-Yu Hsieh & Tingjun Hou. (2023) Integrating multi-modal deep learning on knowledge graph for the discovery of synergistic drug combinations against infectious diseases. Cell Reports Physical Science 4:8, pages 101520.
Crossref
Crossref
VV Strakhov, MK Korsakov, VN Fedorov, VP Vdovichenko, AA Shetnev, AA Popova & NN Volkhin. (2023) Carbonic anhydrase inhibitors for the treatment of glaucoma. Медицинская этика:2023(1).
Crossref
Crossref
Sapna Sinha, Wesam Shamseldin Shalaby, Wendy W. Liu, Reza Razeghinejad & L. Jay Katz. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
612
661
.
Alok Dixit, Atul Ashish & Reena Sharma. (2020) A comparative study on efficacy of fixed combination timolol/brinzolamide versus travoprost monotherapy in drug-naïve open-angle glaucoma patients. Therapeutic Advances in Ophthalmology 12, pages 251584142090966.
Crossref
Crossref
Yuhong Chen, Kuan Jiang, Gang Wei & Yi Dai. 2019. Medical Treatment of Glaucoma. Medical Treatment of Glaucoma
87
113
.
MaryS Galose, HebaM Elsaied, TamerA Macky & PakinamH Fouad. (2016) Brinzolamide/timolol versus dorzolamide/timolol fixed combinations: A hospital-based, prospective, randomized study. Indian Journal of Ophthalmology 64:2, pages 127.
Crossref
Crossref
Chun-Yuan Wang, Ying-Ying Chen & Catherine Jui-Ling Liu. (2012) Assessing the safety and efficacy of switching to brinzolamide/timolol fixed combination as a replacement therapy in patients with uncontrolled intraocular pressure in Taiwan. Taiwan Journal of Ophthalmology 2:3, pages 85-88.
Crossref
Crossref
Italo Giuffre. (2012) Comparative Evaluation of the Efficacy of the Bimatoprost 0.03%, Brimonidine 0.2%, Brinzolamide 1%, Dorzolamide 2%, and Travoprost 0.004%/Timolol 0.5%-Fixed Combinations in Patients Affected by Open-Angle Glaucoma. Open Journal of Ophthalmology 02:04, pages 122-126.
Crossref
Crossref